Professional Documents
Culture Documents
Drug Study SLMC
Drug Study SLMC
CLASSIFICATION
DOSAGE
MECHANISM OF ACTION
INDICATION
CONTRAINDICATION SIDE NURSING EFFECTS/ADVERSE RESPONSIBILITIES EFFECTS Paracetamol should not be used in: hypersensitivity to the preparation and in severe liver diseases -Cramping -heartburn -abdominal distention
o o
600mg
Inhibits the Mild pain synthesis Fever of prostaglandins that may serve as mediators of pain and fever, primarily in the CNS
-If to be given as analgesia, assess onset, type, location, duration of pain. -Can be given without regards to meals. -Tablets can be crushed. -Assess temperature directly before and 1 hour after giving medication. - Evaluate for therapeutic response: relief of pain, stiffness, swelling; increasing in joint mobility; reduced joint tenderness.
o o
DRUG NAME
CLASSIFICATION
DOSAGE
MECHANISM OF ACTION
INDICATION
CONTRAINDICATION
SIDE EFFECTS/ADVERSE EFFECTS -restlessness -drowsiness -fatigue -insomnia -Dizziness -Anxiety -transient Hypertension -nausea - diarrhea
NURSING RESPONSIBILITIES
Antiemetic
10mg
Stimulates motility of upper GI tract without stimulating gastric, biliary, or pancreatic secretions; appears to sensitize tissues to action of acetylcholine.
Contraindicated with -allergy to metoclopramide -GI hemorrhage -Mechanical obstruction or perforation -Epilepsy -Use cautiously with previously detected breastcancer -lactation -pregnancy -fluid overload -renal impairment
Assess: -History: allergy to metoclopramide, - GIhemorrhage -mechanical obstruction or perforation -depression -epilepsy -lactation -previously detected breast cancer -Physical: orientation -reflexes -affect -bowel sounds -normal output -Monitor BPcarefully
DRUG NAME
CLASSIFICATION DOSAGE
MECHANISM OF ACTION
INDICATION
GENERIC NAME:
BRAND NAME:
DRUG NAME
CLASSIFICATION DOSAGE
MECHANISM OF ACTION
INDICATION
GENERIC NAME:
BRAND NAME:
DRUG NAME
CLASSIFICATION DOSAGE
MECHANISM OF ACTION
INDICATION
GENERIC NAME:
BRAND NAME:
DRUG NAME
CLASSIFICATION DOSAGE
MECHANISM OF ACTION
INDICATION
GENERIC NAME:
BRAND NAME:
DRUG NAME
CLASSIFICATION DOSAGE
MECHANISM OF ACTION
INDICATION
GENERIC NAME:
BRAND NAME:
DRUG NAME
CLASSIFICATION DOSAGE
MECHANISM OF ACTION
INDICATION
GENERIC NAME:
BRAND NAME:
DRUG NAME
CLASSIFICATION DOSAGE
MECHANISM OF ACTION
INDICATION
GENERIC NAME:
BRAND NAME:
DRUG NAME
CLASSIFICATION
DOSAGE
MECHANISM OF ACTION
INDICATION
CONTRAINDICATION
SIDE EFFECTS/ADVERSE EFFECTS -drowsiness -abnormal thinking -dizziness -euphoria - headache - dyspnea -abnormal taste - diarrhea -dry mouth -dyspepsia - GI pain - nausea
NURSING RESPONSIBILITIES
30mg
- Inhibits prostaglandi n synthesis, producing peripherally mediated analgesia - Also has antipyretic and antiinflammatory properties. - Therapeutic effect: Decreased
Short term managemen t of pain (not to exceed 5 days total for all routes combined)
Hypersensitivity - Cross-sensitivity with other NSAIDs may exist Pre- or perioperative use - Known alcohol intolerance. Use cautiously in: 1) History of GI bleeding 2) Renal impairment (dosage reduction may be required) 3) Cardiovascular disease
-Patients who have asthma, aspirininduced allergy, and nasal polyps are at increased risk for developing hypersensitivity reactions. Assess for rhinitis, asthma, and urticaria. - Assess pain (note type, location, and intensity) prior to and 1-2 hr following
pain
administration. - Ketorolac therapy should always be given initially by the IM or IV route. Oral therapy should be used only as a continuation of parenteral therapy. - Caution patient to avoid concurrent use of alcohol, aspirin, NSAIDs, acetaminophen, or other OTC medications without consulting health care professional.